Over 25,000 ways to be sure

black silhouettes of individuals and families of all ages encircling a globe

As Best Doctors EMEAA reaches over 25,000 cases, we take a moment to reflect on what getting a second medical opinion really means for patients, their loved ones and their doctors.

Offering access to expert second medical opinions and advice for over 30 million people around the world and in more than 100 countries, Best Doctors understands what it means to be facing a medical condition. We know what questions can arise, the doubts that people struggle with. Yet while no two cases are the same, we have one thing in common: we all want to be sure. When it comes to our health, being sure can mean different things: A definitive diagnosis for our symptoms Confirmation that we are following the right treatment plan Reassurance that we are in the best hands with our Read more

Innovations in the fight against skin cancer

a yellow warning triangle with a drawing of the sun inside

Skin cancer is the most common type of cancer in New Zealand, with an estimated 67,000 cases treated each year. Indeed, New Zealand and Australia have the world’s highest rates of melanoma, the most lethal form of cancer. According to the Sun Smart health promotion agency, melanoma claims the same number of New Zealanders each year as those who die in car accidents, and it is the fourth most common cancer in New Zealand. In today’s post we look at two innovations, one in melanoma treatment and the other in skin cancer prevention.

Virotherapy towards a cure An international research team has found a way to use a genetically engineered version of the herpes virus (the virus responsible for cold sores) as a treatment for aggressive melanoma. The treatment, an example of “virotherapy”, is still pending license. However, the trial results are promising: Over 400 patients from the US, the UK, Canada and South Africa 1 in 4 patients responded to treatment 16% still in remission after 6 months 10% in “complete remission” (no trace of remaining cancer) The study, the largest randomised trial of its kind, is the first time a virus has been used to treat melanoma and, Read more

Beyond the Ice Bucket Challenge: an interview with ALS expert Professor Ammar Al-Chalabi, Part Two

: a drawing of ten faceless people, connected to one another by dashed lines. They all wear different types of clothes and hold overturned buckets above their heads, from which drops of water fall to create puddles

In honour of ALS/MND Global Day on June 21, Best Doctors is pleased to feature Part Two of an interview with Prof. Ammar Al-Chalabi, a leading ALS specialist at King’s College London and director of STRENGTH, the world’s largest international consortium for studying the disease.

Part Two Professor of Neurology and Complex Disease Genetics at King’s College London, Director of King’s MND Care and Research Centre and Honorary Consultant Neurologist at King’s College Hospital, Prof Al- Chalabi is a recognised specialist in ALS (amyotrophic lateral sclerosis, also known as motor neuron disease) whose work involves both clinical practice and research. You are the director of STRENGTH, the largest international consortium for studying ALS in the world. What is special about STRENGTH in terms of its focus and goals? STRENGTH brings together researchers and clinicians from ALS centres across Europe to combine forces, with a focus on collecting and Read more